Characteristics of Academic Inventors on Government-Linked US Drug Patents - O'Neill : O'Neill

JAMA | November 21, 2024

Latest publications See All

Op-Ed

March 13, 2026

IRA Litigation: Pharma’s Failed Challenges To Medicare Drug Pricing

Op-Ed

March 11, 2026

Thousands of Americans with HIV at Risk of Losing Access to Lifesaving Care

Quick Take

March 10, 2026

State Strategies to Sustain an Effective HIV Response